GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » ROA %

Giant Biogene Holding Co (HKSE:02367) ROA % : 35.47% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Giant Biogene Holding Co's annualized Net Income for the quarter that ended in Dec. 2023 was HK$1,717 Mil. Giant Biogene Holding Co's average Total Assets over the quarter that ended in Dec. 2023 was HK$4,841 Mil. Therefore, Giant Biogene Holding Co's annualized ROA % for the quarter that ended in Dec. 2023 was 35.47%.

The historical rank and industry rank for Giant Biogene Holding Co's ROA % or its related term are showing as below:

HKSE:02367' s ROA % Range Over the Past 10 Years
Min: 15.86   Med: 30.73   Max: 38.1
Current: 36.13

During the past 5 years, Giant Biogene Holding Co's highest ROA % was 38.10%. The lowest was 15.86%. And the median was 30.73%.

HKSE:02367's ROA % is ranked better than
98.95% of 1900 companies
in the Consumer Packaged Goods industry
Industry Median: 2.98 vs HKSE:02367: 36.13

Giant Biogene Holding Co ROA % Historical Data

The historical data trend for Giant Biogene Holding Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co ROA % Chart

Giant Biogene Holding Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
30.73 38.10 15.86 17.02 35.51

Giant Biogene Holding Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
ROA % Get a 7-Day Free Trial - 10.63 35.99 37.67 35.47

Competitive Comparison of Giant Biogene Holding Co's ROA %

For the Household & Personal Products subindustry, Giant Biogene Holding Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Giant Biogene Holding Co's ROA % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's ROA % distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's ROA % falls into.



Giant Biogene Holding Co ROA % Calculation

Giant Biogene Holding Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1587.897/( (3504.502+5439.448)/ 2 )
=1587.897/4471.975
=35.51 %

Giant Biogene Holding Co's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1716.824/( (4241.702+5439.448)/ 2 )
=1716.824/4840.575
=35.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Giant Biogene Holding Co  (HKSE:02367) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=1716.824/4840.575
=(Net Income / Revenue)*(Revenue / Total Assets)
=(1716.824 / 4196.71)*(4196.71 / 4840.575)
=Net Margin %*Asset Turnover
=40.91 %*0.867
=35.47 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Giant Biogene Holding Co ROA % Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Giant Biogene Holding Co (HKSE:02367) Business Description

Traded in Other Exchanges
N/A
Address
No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines